LB1005 Suppression of NRAS-mutant melanoma growth with NRAS-targeting ASO treatment reveals therapeutically relevant kinase co-dependencies

Autor: FEICHTENSCHLAGER, V., Zheng, Y.J., Qu, T., Hohlova, D., Callanan, C., Chen, L., Chen, C., Ho, W., Lee, A., Hwang, Y., Muñoz, D.P., Rappersberger, K., Coppe, J., Ortiz-Urda, S.
Zdroj: In Journal of Investigative Dermatology August 2024 144(8) Supplement:S177-S177
Databáze: ScienceDirect